Growth Stocks With Potential To Double Dividends

Dear Reader, find below a list of Growth Stocks With Potential To Double Dividends . Creating such high-quality content is hard work and takes a lot of time. You might have noticed that we don't display ads or get paid for our posts. We deliver this information for free.

To keep this blog running free without ads, we need your help. For a small donation by using this link or clicking the paypal donation pic below, you can help us to keep this blog alive. As gift for your support, we send you our full Dividend Growth Stock Factbook Collection with over 800+ long-term dividend growth stocks in PDF and Excel. You can also join our distribution list for this life-time service for free. Thank you for supporting us.

Ticker	Company	P/E	Fwd P/E	P/S	P/B	Dividend	Get the PDF via Mail…
BCPC	Balchem Corporation	52.59	35.98	5.89	5.60	0.36%	Stock Report of BCPC
ODFL	Old Dominion Freight Line, Inc.	28.16	20.83	3.56	5.29	0.33%	Stock Report of ODFL
AYI	Acuity Brands, Inc.	22.34	16.59	1.83	4.08	0.32%	Stock Report of AYI
CGNX	Cognex Corporation	36.33	36.88	11.88	9.26	0.31%	Stock Report of CGNX
BDC	Belden Inc.	52.96	10.44	1.15	2.16	0.28%	Stock Report of BDC
MMS	MAXIMUS, Inc.	22.18	19.08	1.7	4.05	0.28%	Stock Report of MMS
NVDA	NVIDIA Corporation	40.39	33.64	13.89	18.52	0.22%	Stock Report of NVDA
OLED	Universal Display Corporation	77.4	34.25	20.66	8.77	0.20%	Stock Report of OLED
CMD	Cantel Medical Corp.	48.94	32.58	4.75	6.65	0.18%	Stock Report of CMD
HEI	HEICO Corporation	53.26	43.96	6.21	9.07	0.13%	Stock Report of HEI
RDN	Radian Group Inc.	8.87	7.39	3.48	1.35	0.05%	Stock Report of RDN
CI	Cigna Corporation	17.96	13.26	1.11	3.31	0.02%	Stock Report of CI

Ticker	Company	Sales past 5Y	Sales Q/Q	EPS Q/Q	EPS next 5Y	Perf Year
BCPC	Balchem Corporation	13.90%	11.30%	18.1%	24.0%	44.34%
ODFL	Old Dominion Freight Line, Inc.	9.50%	23.10%	66.7%	19.3%	49.83%
AYI	Acuity Brands, Inc.	12.60%	5.90%	-5.1%	10.0%	-2.52%
CGNX	Cognex Corporation	18.20%	18.60%	0.6%	27.4%	5.25%
BDC	Belden Inc.	5.30%	9.50%	-22.7%	10.2%	-9.71%
MMS	MAXIMUS, Inc.	18.50%	-0.40%	5.4%	12.5%	0.93%
NVDA	NVIDIA Corporation	17.80%	40.00%	91.0%	17.2%	56.96%
OLED	Universal Display Corporation	32.20%	-64.50%	-81.1%	31.8%	-2.56%
CMD	Cantel Medical Corp.	14.80%	13.10%	3.9%	18.0%	11.92%
HEI	HEICO Corporation	11.20%	19.00%	45.8%	18.4%	59.08%
RDN	Radian Group Inc.	6.20%	5.40%	854.8%	15.0%	13.71%
CI	Cigna Corporation	7.40%	10.10%	4.3%	14.5%	11.06%

Top Yielding Pharmacy Benefit Management (PBM) - Health Care Plans Stocks

Find below the top yielding Pharmacy Benefit Management stocks.

Ticker	Company	Market Cap	P/E	P/S	P/B	Dividend	Get the PDF via Mail…
CVS	CVS Health Corporation	65.93B	12.86	0.35	1.7	3.08%	Security Analysis of CVS
UNH	UnitedHealth Group Incorporated	243.48B	23.81	1.14	5.22	1.17%	Security Analysis of UNH
ANTM	Anthem, Inc.	66.73B	21.07	0.74	2.32	1.16%	Security Analysis of ANTM
AET	Aetna Inc.	61.87B	17.3	1.02	3.55	1.06%	Security Analysis of AET
HUM	Humana Inc.	44.65B	30.35	0.81	4.37	0.62%	Security Analysis of HUM
CI	Cigna Corporation	45.88B	16.87	1.05	3.11	0.02%	Security Analysis of CI

If you like our content, subsribe to free our e-mail list or give us a little donation. As a gift, you will get the the Dividend Yield Factbook Collection.

14 Attractively Valued Healthcare Sector Dividend Growth Stocks

Healthcare stocks have generally been poor performers in calendar year 2016. I suggest that this weak performance, especially relative to high-quality, fundamentally sound healthcare stocks, can be somewhat attributable to political uncertainty regarding the future of healthcare.

On the other hand, political uncertainty manifesting in 2016 could also be looked at as the catalyst that is bringing healthcare stocks that were overvalued in 2015 down to fundamentally justified levels.

Below are 14 examples that I consider worthy of current consideration and a more comprehensive research and due diligence effort.

These 14 dividend growth healthcare stocks are currently trading at very attractive fundamental valuations. As a result, they all reflect high earnings and cash flow yields. 

This implies that their valuations are attractive relative to their fundamental values. The following portfolio review lists them in order of highest current dividend yield to lowest.

Each of the results has a low forward P/E under 15 with solid earnings growth perspectives.

Here are the results...

Cracking The Best Healthcare Dividend Stock Secret

This Weekend my eyes and thoughts curved around the Healthcare sector. 

I read several interesting articles from the sector, mostly about the biotech’s and new Hepatitis C drugs from Gilead, Sovaldi and Harvoni.

Those are very expensive drugs with potential to kill the current medical systems but they also generate tons of cash for their corporate.

I also noticed that the Healthcare sector grows at a much faster pace than the economy does, with 10+ percent. How can you benefit from this trend? I don't know. Prices are high, even on free cash flow basis.

Second, the old synthetic drug cash cow system from Pfizer doesn't work anymore. PFE is losing revenues. Even Teva, a generic drug manufacturer, struggles.

In order to get an overview about modest valuated growth stocks from the Healthcare sector, I've created a screen for large capitalized sector members with the following main criteria:

- EPS growth next five years: over 5 percent

- Sales growth past five years: over 5 percent

- Forward P/E under 20

- Positive Dividend

14 attractive healthcare growth stocks remain. It's a very selective list with focus on sales and earnings growth. You can find the full results attached. 

You may also interested in my older articles about healthcare dividend stocks.

Below are also five of my favorites. Which stocks do you like? Please let me know.

David Einhorn's Latest Portfolio Dividend Stock Changes | Greenlight Capital

Latest stock purchases and sales from David Einhorn, Greenlight Capital originally published at long-term-investments.blogspot.com. David Einhorn has around USD 5.3 billion in assets under management in his asset management company Greenlight Capital. Last Quarter he made 28 transactions and bought 7 new stakes. His portfolio has only 30 stock holdings.

In this article I would like to present you the best dividend stocks, bought and sold by David Einhorn. From his nine stock and ETF purchases pay six a dividend. All of the latest dividend buys from David Einhorn yielding between .13 percent and 1.92 percent. David is no long-term dividend player. He wants a quick total return. The most important buys were ING US, Liberty Global and Market Vectors Gold Miners ETF.

On the short side, he reduced or sold out 19 stocks. 15 of them pay a dividend. The biggest impact had Cigna, Seagate Technology and Microsoft with around 3 percent impact to his portfolio.

Apple remains the biggest stock holding bet. The stake has a value of around one billion dollar. The second biggest position of David Einhorn is the car company General Motors which represents around 10.7 percent of his total portfolio. The third biggest company is the technology stock Marvell with a 9.7 percent share. Both are worth over USD 500 million.

17 High Momentum Healthcare Dividend Stocks

Healthcare dividend stocks with highest beta ratios originally published at long-term-investments.blogspot.com. You know that I am a conservative investor and try to minimize my risk.

This strategy is necessary if you have a larger amount of money to take care of or you begin to cry when you lose 10 percent on your book value. The second disadvantage is that you lose performance in a strong up moving market. 

Since 2009, there were nearly no bigger corrections at the market but with low beta and safe haven stocks, your performance would be only half of the return from the markets. What you need to get a push for your portfolio is a high beta stock. I don’t recommend buying them because it’s a definitely riskier strategy and nobody knows when the market turns into a bearish mood.

However, let’s take a look at the high fly momentum stocks from the healthcare sector. Those are stocks with the highest beta ratio from the sector. They have a beta between 1 and 2. With focus on the dividend paying stocks, only 17 stocks from the healthcare sector pay a dividend and being correlated with the market by a factor of up to 2.

One High-Yield is below the results and 16 have a current buy or better rating by brokerage firms.

54 Large Cap Dividend Stocks At All-Time Highs And Which To Buy

High capitalized dividend stocks at All-Time-High prices originally published at long-term-investments.blogspot.com. Only a rising stocks is a good stock if you are invested. The markets are really bullish after FED chairman Bernanke has flooded the market with cheap money over the recent years. As a result, the many stock markets all over the world hit all-time highs. But not all stocks are winners.

I’ve screened the market by large capitalized stocks at All-Time-Highs. 76 companies have reached this goal and 54 of them pay good dividends. It looks like stocks at new highs are also highly priced. That’s not true. 30 of the top results still have a forward P/E below 15.

Below is a small list of the dividend stocks at new All-Time-Highs with forward P/E’s fewer than 15 as well as double-digit earnings growth predictions for the next five years. Eleven companies fulfilled these criteria.

Dodge & Cox's Latest Dividend Stock Buys And Income Holdings

Dodge & Cox fund investing strategies originally published at long-term-investments.blogspot.com. The Dodge & Cox fund is a real equity based investment vehicle with around USD 81.3 billion in assets under management.

The investment firm was founded in 1930, by Van Duyn Dodge and E. Morris Cox. With this long history in background, there is also a long performance review available. 

Over the recent years, the fund’s performance suffered a bit. There was a small underperformance of 2.7 percent over the recent three years and 9.2 percent over the past five years. The excess gain to the S&P 500 over the longer term was also small with up to 2.9 percent at the peak (15 years).

They own in total 163 companies of which two were recently new in the fund. Kraft Foods Group and Abbvie are the two names.

Dodge & Cox have a real focus on financial, healthcare and technology stocks. More than half of their funds (59.9 percent) are invested in these three stock categories. The biggest impact on the buy side had the technology sector which is now net 0.7 percentage points bigger compared to the previous quarter.

Dodge & Cox have a dividend focus and they like large capitalized stocks. From their 20 biggest stock buys and sells in Q1/13 pay 17 a solid dividend and 17 have a valuation over USD 10 billion. Hewlett Packard is the biggest holding, worth around USD 4 billion. The latest big stock increases are up 26.03 percent year-to-date.

David Einhorn’s Best Yielding Dividend Stock Buys

David Einhorn and his highest yielding dividend stock buys originally published at "long-term-investments.blogspot.com". On May 15, a full range of professional fund managers released its quarter statements. Today I like to look at the best dividend stock buys of David Einhorn. He is the head of Greenlight Capital and serves around 6.5 billion in assets. In total he has 38 stocks of which six were bought within the recent quarter. Below is a list of his 20 biggest transaction within the recent quarters.

His biggest move was related to Apple. He added the position by 83.45%, a change to his portfolio of 7.37%.

15 of his 20 largest stock buys from the recent quarters are dividend stocks. Apple is his biggest bet with a value above a billion dollar.

8 Cheap Dividend Stocks That Crossed New 52-Week Highs

Dividend Stocks Close At New Highs By Dividend Yield – Stock, Capital, Investment. Here is a current sheet of dividend stocks (positive yield) that have marked a new 52-Week High within the recent days. Despite the turmoil’s at the markets, there are 65 companies at one-year highs and 33 of them pay dividends. I screened the best performing stocks and analyzed all with a P/E ratio below 15 and a positive yield. Eight companiesfulfilled these criteria of which three have a buy or better recommendation.